Director's Dealings

RNS Number : 3166E

Futura Medical PLC

17 December 2009

 



For immediate release

17 December 2009

Futura Medical plc

("Futura" or "the Company")

Director's Dealings

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that it has received notification from James Barder, the Chief Executive of the Company, that he and his wife have today gifted in aggregate 100,000 ordinary shares in the Company to a shareholding account jointly held by their children.  

For the purposes of the AIM Rules for Companies, Mr Barder will continue to treat such shares as consolidated within his and his wife's holding and as such his aggregate beneficial and non-beneficial holdings will remain unchanged at 720,212 ordinary shares.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Stasa Filiplic / Jennie Spivey	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com 

 

END

 

 

MSCFGMMZDNVGLZM